发明公开
- 专利标题： PPAR MODULATORS
- 专利标题（中）： PPAR-MODULATOREN
-
申请号： EP04779442.5申请日： 2004-08-17
-
公开(公告)号： EP1660428A1公开(公告)日： 2006-05-31
- 发明人: GONZALEZ VALCARCEL, Isabel, Cristina , MANTLO, Nathan, Bryan , SHI, Qing , WANG, Minmin , WINNEROSKI, Leonard, Larry, Junior , XU, Yanping , YORK, Jeremy, Schulenburg
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 代理机构： Burnside, Ivan John
- 优先权： US496549P 20030820
- 国际公布： WO2005019151 20050303
- 主分类号： C07C59/68
- IPC分类号： C07C59/68 ; A61K31/095 ; A61K31/185 ; A61P3/04 ; A61P3/10
摘要：
The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
信息查询
